Twenty-eight patients with anaerobic pleuropulxnonary infections were treated with clindamycin alone or clindamycin with gentamicin. Sixteen of the patients presented with pneumonitis, nine with necrotizing pneumonia, and three with lung abscesses. The average length of treatment was 13.8 days, and the duration of temperature after initiation of therapy was 3.1 days. The predominant isolates were anaerobic gram-positive cocci (23 isolates), Bacteroides melaninogenicus (14), Bacteroides fragilis (9) , and Fusobacterium nucleatum (11) . The most frequent aerobic isolates were alpha-hemolytic streptococci (12), Diplococcus pneumoniae (12), Pseudomonas aeruginosa (9), Klebsiella pneumoniae (7) , group A beta-hemolytic streptococci (5) , Staphylococcus aureus (9) , and Escherichia coli (6) . All patients responded to the therapy and were cured of the infection. There were no side effects observed from the administration of clindamycin. None of the patients developed any blood dyscrasia, liver damage, diarrhea, or colitis. Clindamycin appears to be effective in the treatment of mixed aerobic and anaerobic pleuropulmonary infections in children, alone or with an aminoglycoside when indicated.
Aspiration pneumonia is common in pediatric patients who suffer from acute or chronic neurological disorder which alters their consciousness, gag reflex, or swallowing mechanism. The aerobic and anaerobic bacteriology of such infections has been studied in adults (1, 6), using transtracheal aspiration or direct lung puncture. Aspiration pneumonia in children, however, has not been studied in the past with the above methods, which allow bypass of the normal mouth flora.
The role of anaerobic bacteria in aspiration pneumonia in pediatric patients was recently demonstrated (I. Brook and S. M. Finegold, Pediatr. Res. 11:568, 1977) . It was found that the isolates from those patients are usually a mixture of aerobic and anaerobic organisms.
Selection of appropriate antimicrobial therapy for aspiration pneumonia may be difficult, particularly if one of the causative organisms is Bacteroides fragilis. This pathogen is generally resistant to antibiotics used in the treatment of systemic infections, including penicillin. Recent in vitro and clinical data (3, 7) suggest that anaerobic bacteria are usually susceptible to clindamycin. We present our experience using clindamycin alone or combined with an aminoglycoside in the treatment of aspiration pneumonia in pediatric patients. The second group of patients, treated with clindamycin and gentamicin, consisted of six patients with pneumonitis, four with necrotizing pneumonia, and two with lung abscesses. The bacteriology of those patients is presented in Table 2 . There are some differences between the bacteria in the two groups. Gram-negative aerobic bacilli, especially Pseudomonas aeruginosa, Escherichia coli, Klebsiella pneumoniae, and Serratia marcesens were more frequently isolated in the second group, which also accounted for the higher ratio of bacteria per specimen in that group. Fusobacterium nucleatum was more frequently isolated in the second group, whereas ninogenicus (14), B. fragilis (9) , and F. nucleadany-Clindamycin tum (11) . The most frequent aerobic isolates cin and gentamicin were alpha-hemolytic streptococci (12 isolates), Streptococcus pneumoniae (12), P. aeruginosa (9), K. pneumoniae (7), Staphylococcus aureus 7 5 (9), E. coli (6) , and group A beta-hemolytic streptococci (5) . The bacteriology of the tracheal 8 4 aspirates demonstrated the polymicrobial etiology of the aspiration pneumonia, with an aver- 
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